JPH10503202A - アザスピラン類を用いる日和見感染の治療方法 - Google Patents

アザスピラン類を用いる日和見感染の治療方法

Info

Publication number
JPH10503202A
JPH10503202A JP8505798A JP50579896A JPH10503202A JP H10503202 A JPH10503202 A JP H10503202A JP 8505798 A JP8505798 A JP 8505798A JP 50579896 A JP50579896 A JP 50579896A JP H10503202 A JPH10503202 A JP H10503202A
Authority
JP
Japan
Prior art keywords
compound
formula
treatment
opportunistic infections
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8505798A
Other languages
English (en)
Japanese (ja)
Inventor
バジャー，アリソン・メアリー
バジェルスキー，ピーター・ジョン
ヘルジック，ダヌタ・ジェイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of JPH10503202A publication Critical patent/JPH10503202A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP8505798A 1994-07-23 1995-07-14 アザスピラン類を用いる日和見感染の治療方法 Pending JPH10503202A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods
GB9414902.8 1994-07-23
PCT/US1995/008915 WO1996003126A1 (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes

Publications (1)

Publication Number Publication Date
JPH10503202A true JPH10503202A (ja) 1998-03-24

Family

ID=10758802

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8505798A Pending JPH10503202A (ja) 1994-07-23 1995-07-14 アザスピラン類を用いる日和見感染の治療方法

Country Status (15)

Country Link
EP (1) EP0804201A4 (hu)
JP (1) JPH10503202A (hu)
KR (1) KR970704446A (hu)
CN (1) CN1157564A (hu)
AU (1) AU684384B2 (hu)
BR (1) BR9508332A (hu)
CA (1) CA2195778A1 (hu)
CZ (1) CZ286482B6 (hu)
GB (1) GB9414902D0 (hu)
HU (1) HUT77379A (hu)
MX (1) MX9700626A (hu)
NO (1) NO310096B1 (hu)
NZ (1) NZ290974A (hu)
WO (1) WO1996003126A1 (hu)
ZA (1) ZA956098B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (pt) * 1991-06-07 1999-06-30 Smithkline Beecham Corp Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso

Also Published As

Publication number Publication date
MX9700626A (es) 1997-05-31
BR9508332A (pt) 1997-11-04
ZA956098B (en) 1996-05-23
HUT77379A (hu) 1998-04-28
GB9414902D0 (en) 1994-09-14
NO310096B1 (no) 2001-05-21
CZ20997A3 (en) 1997-10-15
CN1157564A (zh) 1997-08-20
CZ286482B6 (en) 2000-04-12
NO970284L (no) 1997-03-19
KR970704446A (ko) 1997-09-06
NO970284D0 (no) 1997-01-22
EP0804201A1 (en) 1997-11-05
WO1996003126A1 (en) 1996-02-08
HU9700201D0 (en) 1997-04-28
NZ290974A (en) 1999-08-30
AU684384B2 (en) 1997-12-11
AU3190995A (en) 1996-02-22
EP0804201A4 (en) 2000-04-26
CA2195778A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
EP2632451B1 (en) Use of malononitrilamides in neuropathic pain
RU2124364C1 (ru) Эндопаразитицидное средство
HUT71235A (en) Pharmaceutical compositions against endometriosis containing 2-phenyl-3-aroil-benzotiophene derivatives and process for their preparation
NO339794B1 (no) Beskyttende middel for en retinal neuronal celle med et prostaglandin F2αderivat som aktiv bestanddel
SK170999A3 (en) Compositions for treating and preventing arterial thrombosis and use of a factor xa inhibitor on its own and/or combined with a platelet antiaggregating agent
CZ285339B6 (cs) Použití riluzolu pro přípravu léčiv určených pro léčení neuronální degenerace způsobené AIDS
KR101152308B1 (ko) 항구토제와 엔케팔리나제 억제제의 배합물
EP3453704A1 (en) Phenol compound and combination of same with a benzodiazepine fused to 1,4-dihydropyridine for treating diseases of the central nervous and vascular systems
EP1567138A1 (en) Use of diamide derivatives for inhibiting chronic tissue transplant rejection
KR20120100262A (ko) 부추로부터 분리된 신규 화합물 및 그 화합물의 항바이러스제로서의 용도
JPH10503202A (ja) アザスピラン類を用いる日和見感染の治療方法
JPH08507774A (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
US5786376A (en) Methods of treating opportunistic infections with azaspiranes
WO1995007282A1 (fr) Antidepresseur
JP2000510114A (ja) 抗酸化剤化合物
Marchiondo et al. In vivo efficacy and ultrastructural effects of mitomycin C against experimental alveolar hydatid disease
DK168191B1 (da) Anvendelse af peroxydiphosphater til fremstilling af farmaceutiske tabletter eller farmaceutiske vandige opløsninger
EP3552605A1 (en) Mcoppb for use as medicament
JP2011144111A (ja) 軸性近視の予防または治療剤
US3852454A (en) Treatment of rheumatoid arthritis
JPH09500646A (ja) アザスピランによるｈｉｖの治療法
CN111138438B (zh) 一种吡唑并嘧啶酮类化合物及其组合物在防治军事噪声性听力损失方面的应用
JPH09500648A (ja) 置換アザスピランによるヒト免疫不全ウイルス複製の阻害法
WO2024163598A3 (en) Peptides comprising thioester groups, including depsipeptide thioesters, methods of making, and use thereof
JP2005520806A (ja) がん治療を改善する併用療法におけるキナゾリノン化合物